throbber

`
`
`
`DEPARTMENT OF HEALTH AND HUMAN SERVICES
`
`
`
`
`
`
`
` NDA 019516/S-043
`
` NDA 022272/S-023
`
`
`
`
`
`
`Food and Drug Administration
`
`
` Silver Spring MD 20993
`
`SUPPLEMENT APPROVAL
`
`
` Purdue Pharma, L.P.
`
` One Stamford Forum
`
` Stamford, CT 06901-3431
`
`
`
`
`Attention: Beth Connelly
`
`
`Associate Director, Regulatory Affairs
`
`
`
`
`Dear Ms. Connelly:
`
`
`
`
`
`
`Please refer to your Supplemental New Drug Applications (sNDAs) dated April 17, 2014,
`
`
`
`
`
`received April 23, 2014, submitted under section 505(b) of the Federal Food, Drug, and
`
`Cosmetic Act (FDCA) for MS CONTIN (morphine sulfate extended-release tablets) and
`
`
`OXYCONTIN (oxycodone hydrochloride extended-release tablets).
`
`
`
`
`
`
`
`These “Changes Being Effected” supplemental new drug applications provide for revised
`
`
`
`immediate container labels for both drugs as well as revised carton labels and blister packs for
`
`OXYCONTIN. The revisions include changing the dosage form from “controlled-release
`
`
`
`
`tablets” to “extended-release tablets,” and changing the established name and dosage form
`
`expression from “ (drug substance controlled-release) Tablets” to “ (drug substance extended-
`
`
`release tablets)” to conform with FDA and USP current standards.
`
`
`APPROVAL & LABELING
`
`We have completed our review of this supplemental application and it is approved, effective on
`
`
`
`
`
`the date of this letter, for use as recommended in the enclosed, agreed-upon labeling text.
`
`
`
`CARTON AND IMMEDIATE CONTAINER LABELS
`
`
`
`We acknowledge your April 17, 2014, submissions containing final printed carton and container
`
`
`
`labels for MS CONTIN and OXYCONTIN Tablets.
`
`
`
`
`
`REPORTING REQUIREMENTS
`
`
`We remind you that you must comply with reporting requirements for an approved NDA
`
`
`
`(21 CFR 314.80 and 314.81).
`
`
`
`
`Reference ID: 3646951
`
`

`

`
`
`
`
`
`
`
`Sincerely,
`
`
`{See appended electronic signature page}
`
`
`Sharon Hertz, MD
`
`Acting Director
`
`
`Division of Anesthesia, Analgesia,
`
`
`and Addiction Products
`
`
`Office of Drug Evaluation II
`
`Center for Drug Evaluation and Research
`
`
`
` NDA 019516/S-043
`
` NDA 022272.S-023
`
` Page 2
`
`
` If you have any questions, call Lisa Basham, Senior Regulatory Health Project Manager, at (301)
`
`
` 796-1175.
`
`
`
`
`
`
`
`
`ENCLOSURE:
`
`
`
`Carton and Container Labels
`
`
`Reference ID: 3646951
`
`

`

`---------------------------------------------------------------------------------------------------------
`This is a representation of an electronic record that was signed
`electronically and this page is the manifestation of the electronic
`signature.
`---------------------------------------------------------------------------------------------------------
`/s/
`----------------------------------------------------
`
`SHARON H HERTZ
`10/22/2014
`
`Reference ID: 3646951
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket